Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $1.449B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $615M | 42.5% | $6.47 | 0.0% | SHS | P8696W104 |
| HRMY | Harmony Biosciences Holdings Inc | 2,606,247 | $91.71M | 6.3% | $36.16 | -4.5% | Common | 413197104 |
| — | Verona Pharma PLC | 4,249,918 | $89.84M | 6.2% | $6.97 | — | ADS | 925050106 |
| — | Avadel Pharmaceuticals PLC | 3,829,577 | $63.11M | 4.4% | $8.41 | — | ADR | 05337M104 |
| TERN | Terns Pharmaceuticals Inc | 6,657,992 | $58.26M | 4.0% | $11.36 | +2.6% | Common | 880881107 |
| GERN | Geron Corp | 16,524,634 | $53.04M | 3.7% | $1.35 | +110.6% | Common | 374163103 |
| TARS | Tarsus Pharmaceuticals Inc | 2,262,200 | $40.88M | 2.8% | $28.48 | -44.2% | Common | 87650L103 |
| VRDN | Viridian Therapeutics Inc | 1,678,207 | $39.92M | 2.8% | $15.47 | +65.8% | Common | 92790C104 |
| — | VectivBio Holding AG | 2,333,300 | $39.36M | 2.7% | $8.66 | — | Common | H9060V101 |
| — | Chinook Therapeutics Inc | 934,879 | $35.92M | 2.5% | $17.37 | — | Common | 16961L106 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $31.69M | 2.2% | $39.31 | -83.3% | Common | 00166B105 |
| COGT | Cogent Biosciences Inc | 2,244,941 | $26.58M | 1.8% | $8.55 | +34.2% | Common | 19240Q201 |
| — | Icosavax, Inc. | 1,704,568 | $16.93M | 1.2% | $9.93 | — | Common | 45114M109 |
| — | Gracell Biotechnologies Inc | 3,969,427 | $15.12M | 1.0% | $6.37 | — | SPONSORED ADS | 38406L103 |
| — | Astria Therapeutics Inc | 1,681,199 | $14M | 1.0% | $11.41 | — | Common | 04635X102 |
| VTYX | Ventyx Biosciences Inc | 422,075 | $13.84M | 1.0% | $18.57 | +85.6% | Common | 92332V107 |
| ACLX | Arcellx Inc. | 433,785 | $13.72M | 0.9% | $32.94 | +16.1% | Common | 03940C100 |
| — | Allakos Inc | 2,988,000 | $13.03M | 0.9% | $6.12 | — | Common | 01671P100 |
| ZLAB | Zai Lab Ltd ADR | 445,505 | $12.35M | 0.9% | $50.07 | — | ADR | 98887Q104 |
| OLMA | Olema Pharmaceuticals Inc | 1,339,271 | $12.09M | 0.8% | $39.90 | -84.9% | Common | 68062P106 |
| VSTM | Verastem Inc | 1,538,461 | $11.45M | 0.8% | $6.94 | 0.0% | Common | 92337C203 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $11.31M | 0.8% | $3.60 | -12.7% | Common | 20454B104 |
| — | Aslan Pharmaceuticals Ltd | 2,840,908 | $10.37M | 0.7% | $3.35 | — | ADS | 04522R101 |
| — | Alpine Immune Sciences Inc | 914,913 | $9.405M | 0.6% | $10.28 | — | Common | 02083G100 |
| ACRS | Aclaris Therapeutics, Inc. | 898,631 | $9.319M | 0.6% | $1.36 | +564.7% | Common | 00461U105 |
| — | Amyris, Inc | 7,750,828 | $7.983M | 0.6% | $3.12 | — | Common | 03236M200 |
| KALV | KalVista Pharmaceuticals Inc. | 856,008 | $7.704M | 0.5% | $15.45 | -40.3% | Common | 483497103 |
| — | Genetron Holdings Ltd | 8,124,174 | $7.556M | 0.5% | $9.86 | — | ADS | 37186H100 |
| — | Instil Bio Inc | 12,486,787 | $6.88M | 0.5% | $25.08 | — | Common | 45783C101 |
| DCTH | Delcath Systems, Inc. | 1,178,787 | $6.872M | 0.5% | $6.27 | 0.0% | Common | 24661P807 |
| DYN | Dyne Therapeutics Inc | 577,642 | $6.498M | 0.4% | $20.78 | -43.2% | Common | 26818M108 |
| WHWK | Aadi Bioscience Inc | 509,572 | $6.456M | 0.4% | $30.48 | -74.5% | Common | 00032Q104 |
| SERA | Sera Prognostics Inc | 1,856,011 | $6.116M | 0.4% | $10.38 | -67.0% | Common | 81749D107 |
| IOBT | IO Biotech Inc | 3,015,545 | $5.895M | 0.4% | $9.66 | -79.8% | Common | 449778109 |
| — | DBV Technologies SA | 2,708,875 | $5.147M | 0.4% | $1.77 | — | Sponsored ADR | 23306J101 |
| — | Bolt Therapeutics Inc | 3,871,291 | $4.955M | 0.3% | $32.91 | — | Common | 097702104 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $4.9M | 0.3% | $40.33 | -14.5% | Common | 04280A100 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $4.612M | 0.3% | $18.48 | -61.3% | Common | 462260100 |
| — | Clene Inc | 4,520,622 | $3.707M | 0.3% | $0.82 | — | Common | 185634102 |
| — | Impel NeuroPharma Inc | 2,884,789 | $3.664M | 0.3% | $8.85 | — | Common | 45258K109 |
| — | Aligos Therapeutics Inc | 3,547,030 | $3.444M | 0.2% | $27.65 | — | Common | 01626L105 |
| BCAB | BioAtla Inc | 637,181 | $1.912M | 0.1% | $8.30 | -58.5% | Common | 09077B104 |
| FULC | Fulcrum Therapeutics Inc | 550,000 | $1.815M | 0.1% | $8.96 | -67.2% | Common | 359616109 |
| IMUX | Immunic Inc | 632,184 | $1.587M | 0.1% | $2.73 | -38.5% | Common | 4525EP101 |
| CDXS | Codexis, Inc | 388,144 | $1.087M | 0.1% | $13.98 | -76.9% | Common | 192005106 |
| RZLT | Rezolute Inc | 489,473 | $969K | 0.1% | $3.32 | -38.1% | Common | 76200L309 |
| — | Homology Medicines, Inc. | 370,068 | $328K | 0.0% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $73,774 | 0.0% | $6.03 | — | Common | 74019P108 |